GGrantIndex
Sort

21,281 grants matching influenza

Broad spectrum protection and immune responses induced by an NP-based universal influenza vaccine in heterologous NHP challenge model

$529,857
Florence Nicolas · Osivax Sas · R01 · FY2023 · AI

Medicare Annual Wellness Visit Practice Redesign Toolkit: A Tailored Intervention to Improve Preventive Health Service Use

$529,696
Derjung M Tarn · University Of California Los Angeles · R33 · FY2022 · AG

Clock Gene Control of Viral Infection and Asthma

$529,692
Jeffrey Adam Haspel · Washington University · R01 · FY2020 · HL

Defining the cellular and molecular mechanism of IDO2 function driving autoimmune vs.protective immune responses

$529,682
Laura Mandik-Nayak · Lankenau Institute For Medical Research · R01 · FY2025 · AR

Viral pathogenesis of chronic inflammatory lesions of the placenta

$529,546
Kristine M. Wylie · Washington University · R01 · FY2023 · HD

Impacts of Individual and Social Behavior on Influenza Dynamics and Control

$529,525
Alison P Galvani · Yale University · U01 · FY2012 · GM

Influenza D Virus Entry and Tissue Tropism

$529,517
Feng Li · University Of Kentucky · R01 · FY2020 · AI

Automating Viral Genome Annotation and Quality Control for Viruses of Public Health Importance

$529,500
Alexander L Greninger · University Of Washington · R03 · FY2025 · LM

Manipulating immunodominance in influenza HA

$529,237
Philip R Dormitzer · Boston Children'S Hospital · P01 · FY2013 · AI

Antibody Responses in HIV and Aging

$529,210
Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2013 · AI

Project 1: Costimulation and Regulation of Anti-viral Immunity

$529,207
Arlene H Sharpe · Harvard Medical School · P01 · FY2015 · AI

Lethal H5N1 Virus Infection and Respiratory Disorders

$529,200
Fadi Xu · Lovelace Biomedical & Environmental Research Institute · R01 · FY2014 · HL

Immune Responses in Otitis Prone Children

$529,185
Michael E Pichichero · Rochester General Hospital (Ny) · R01 · FY2013 · DC

Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component B: Vaccine Manufacturing and Toxicology Core

$529,176
Thomas Denny · Duke University · N01 · FY2025 · AI

Core B: Organoid Core

$529,054
Calvin J Kuo · Stanford University · U19 · FY2022 · AI

Modulation of Human Dendritic Cell Development by Adjuvants and Vaccines

$529,025
Michel C Nussenzweig · Rockefeller University · U19 · FY2018 · AI

Developing a Paramyxovirus-based H5N1 Vaccine

$528,955
Biao He · Pennsylvania State University, The · R01 · FY2009 · AI

Viruses and Hematopoiesis

$528,904
Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL

An Integrated Multilevel Modeling Framework for Repertoire-Based Diagnostics

$528,873
Ramy Arnaout · Beth Israel Deaconess Medical Center · R01 · FY2021 · AI

The Role of Staphylococcus aureus SasD in Lung

$528,628
John F Alcorn · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL

Virtual Patient Cohorts to Illuminate Immunologic Drivers of Influenza Severity

$528,515
Amber M Smith · University Of Tennessee Health Sci Ctr · R01 · FY2022 · AI

Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis

$528,500
Matthew Bryan Frieman · University Of Maryland Baltimore · R01 · FY2014 · AI

True Direct Single Molecule RNA Sequencing

$528,500
Patrice M Milos · Helicos Bioscience Corporation · R01 · FY2010 · HG

KSHV,HIV and the Kaposi's Sarcoma Tumor Niche

$528,369
John T. West · Lsu Health Sciences Center · R01 · FY2024 · CA

Natural and Induced IgM as Regulators of Antiviral Humoral Immunity

$528,352
Nicole Baumgarth · University Of Alabama At Birmingham · U19 · FY2017 · AI